Back to Search Start Over

Anti-Bacterial Adhesion on Abiotic and Biotic Surfaces of the Exopolysaccharide from the Marine Bacillus licheniformis B3-15.

Authors :
Zammuto V
Spanò A
Agostino E
Macrì A
De Pasquale C
Ferlazzo G
Rizzo MG
Nicolò MS
Guglielmino S
Gugliandolo C
Source :
Marine drugs [Mar Drugs] 2023 May 20; Vol. 21 (5). Date of Electronic Publication: 2023 May 20.
Publication Year :
2023

Abstract

The eradication of bacterial biofilm represents a crucial strategy to prevent a clinical problem associated with microbial persistent infection. In this study we evaluated the ability of the exopolysaccharide (EPS) B3-15, produced by the marine Bacillus licheniformis B3-15, to prevent the adhesion and biofilm formation of Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 29213 on polystyrene and polyvinyl chloride surfaces. The EPS was added at different times (0, 2, 4 and 8 h), corresponding to the initial, reversible and irreversible attachment, and after the biofilm development (24 or 48 h). The EPS (300 µg/mL) impaired the initial phase, preventing bacterial adhesion even when added after 2 h of incubation, but had no effects on mature biofilms. Without exerting any antibiotic activity, the antibiofilm mechanisms of the EPS were related to the modification of the (i) abiotic surface properties, (ii) cell-surface charges and hydrophobicity, and iii) cell-to-cell aggregation. The addition of EPS downregulated the expression of genes ( lec A and pslA of P. aeruginosa and clf A of S. aureus ) involved in the bacterial adhesion. Moreover, the EPS reduced the adhesion of P. aeruginosa (five logs-scale) and S. aureus (one log) on human nasal epithelial cells. The EPS could represent a promising tool for the prevention of biofilm-related infections.

Details

Language :
English
ISSN :
1660-3397
Volume :
21
Issue :
5
Database :
MEDLINE
Journal :
Marine drugs
Publication Type :
Academic Journal
Accession number :
37233507
Full Text :
https://doi.org/10.3390/md21050313